Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,842,534
+$2,364,859 QoQ
Shares Held
70,905
-0.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.92%
of 13F equity value
Holder Rank
#665
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PALISADE CAPITAL MANAGEMENT, LP holds $44,577,032 across 7 Drug Manufacturers - General names. ABBV ranks #1 (40.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
70,905 | $17,842,534 | |
| 2 | LLY |
ELI LILLY & Co
|
12,084 | $14,493,913 | |
| 3 | JNJ |
Johnson & Johnson
|
23,321 | $5,922,834 | |
| 4 | NVO |
Novo Nordisk A S
|
113,575 | $5,444,785 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
2,742 | $346,424 | |
| 6 | AZN |
Astrazeneca PLC
|
1,412 | $267,743 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,014 | $258,799 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,842,534 | 70,905 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $15,477,675 | 71,165 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $16,105,803 | 70,488 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $15,830,852 | 68,372 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,575,198 | 67,747 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $14,264,540 | 68,082 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $12,290,798 | 69,166 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,625,725 | 68,998 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,830,420 | 68,974 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $12,413,210 | 68,167 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $13,264,037 | 85,591 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $12,788,006 | 85,791 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $11,575,193 | 85,914 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $14,099,304 | 88,469 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $16,215,462 | 100,337 | Shares | Sole | 2023-03-24 | |
| 2022-09-30 | $14,084,534 | 104,944 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $16,337,117 | 106,667 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $17,437,524 | 107,566 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $14,916,070 | 110,163 | Shares | Sole | 2022-04-21 | |
| 2021-09-30 | $7,592,969 | 70,390 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,887,953 | 70,028 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $7,224,550 | 66,758 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $6,883,851 | 64,245 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $5,420,945 | 61,890 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $5,477,953 | 55,795 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $3,481,730 | 45,698 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||